This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Atrial Fibrillation, Stroke, Thrombo-embolism or Bleeding
and you are
over 18
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to determine that a new drug called "Rivaroxaban®" is effective in preventing patients from forming clots after their heart rhythm has been reset by the cardiologist with an electrical device.

Provided treatments

  • Drug: Rivaroxaban
  • Drug: Warfarin and Enoxaparin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01747746. The sponsor of the trial is John H. Stroger Hospital and it is looking for 33 volunteers for the current phase.
Official trial title:
Anticoagulation With Rivaroxaban in Post Cardioversion Patients